KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $72.2 million.

  • Evolent Health's Accounts Payables rose 4410.92% to $72.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 million, marking a year-over-year increase of 4410.92%. This contributed to the annual value of $96.0 million for FY2024, which is 9903.2% up from last year.
  • Evolent Health's Accounts Payables amounted to $72.2 million in Q3 2025, which was up 4410.92% from $69.5 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Accounts Payables ranged from a high of $96.6 million in Q2 2022 and a low of $37.8 million during Q3 2021
  • Its 5-year average for Accounts Payables is $64.3 million, with a median of $61.9 million in 2022.
  • As far as peak fluctuations go, Evolent Health's Accounts Payables surged by 20049.73% in 2021, and later tumbled by 4928.07% in 2024.
  • Over the past 5 years, Evolent Health's Accounts Payables (Quarter) stood at $96.1 million in 2021, then plummeted by 40.5% to $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then skyrocketed by 99.03% to $96.0 million in 2024, then decreased by 24.83% to $72.2 million in 2025.
  • Its Accounts Payables was $72.2 million in Q3 2025, compared to $69.5 million in Q2 2025 and $57.8 million in Q1 2025.